The Athlete s Heart. Role of Echo. Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University

Similar documents
The Athlete s Heart. Critical Role of Echo. Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University

The Athletic Heart Takes Shape: Overview of Cardiac Remodeling Rory B. Weiner, MD

Athlete s Heart: Clinical Relevance. Athlete's Heart vs. Cardiac Pathology Clinical Approaches. Echo Florida Conflicts of Interest: None

Echo Evaluation of the Heart of an Athlete

Athlete s Heart vs. Cardiomyopathy

Sudden Death in Athletes: What is the role of ECG Screening?

Athlete s Heart vs. Cardiomyopathy

Cardiac hypertrophy : differentiating disease from athlete

Novel echocardiographic modalities: 3D echo, speckle tracking and strain rate imaging. Potential roles in sports cardiology. Stefano Caselli, MD, PhD

Right ventricular adaptation in endurance athletes. António Freitas. No conflict of interest

Nancy Goldman Cutler, MD Beaumont Children s Hospital Royal Oak, Mi

EVALUATION OF THE ATHLETE. Karen Stout, MD Professor, Medicine and Pediatrics University of Washington

Historical Notes: Clinical Exercise Testing in the Athlete. An Efficient Heart. Structural Changes, Cont. Coronary Arteries

Jonathan Kim MD, FACC

HYPERTROPHY: Behind the curtain. V. Yotova St. Radboud Medical University Center, Nijmegen

Risk Factors for Sudden cardiac Death

Professor Sanjay Sharma St George s University of London

CARDIAC BENEFICIAL EFFECTS AND ADAPTATIONS IN ATHLETES

Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations

Screening of Children and Adolescents at Risk of Sudden Cardiac Arrest: What Is the Utility of Non-Invasive Imaging?

Echographic tricky aspects in the athlete's heart

Endurance Exercise and Cardiovascular Health

SABIHA GATI AND SANJAY SHARMA

How NOT to miss Hypertrophic Cardiomyopathy? Adaya Weissler-Snir, MD University Health Network, University of Toronto

Managing Hypertrophic Cardiomyopathy with Imaging. Gisela C. Mueller University of Michigan Department of Radiology

Investigating senior athletes for cardiovascular disease. Antonio Pelliccia, MD

I have nothing to disclose. Research support from: Cardiac Risk in The Young

Hypertrophic Cardiomyopathy or «Athlete s Heart»

LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital

Echocardiographic Evaluation of the Cardiomyopathies. Stephanie Coulter, MD, FACC, FASE April, 2016

La valutazione dell atleta: è una strategia salva-vita e costo-efficace?

Introduction. Abbreviations and Definitions

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.

Restrictive Cardiomyopathy

April 22, 2017 Abraham Rothman, MD

THE CARDIOVASCULAR SYSTEM

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.

Key wards: PR Interval, QT interval, bradycardia.

Aortic valve Stenosis: Insights in the evaluation of LV function. Erwan DONAL Cardiologie CHU Rennes

Athletes with cardiac disease; dead and buried or chance for resurrection?

CLINICAL RESEARCH ON CARDIOVASCULAR ALTERATION ON 86 S PROFESSIONAL ATHLETES IN IRAN

COMPLEX CONGENITAL HEART DISEASE: WHEN IS IT TOO LATE TO INTERVENE?

Cardiac Conditions in Sport & Exercise. Cardiac Conditions in Sport. USA - Sudden Cardiac Death (SCD) Dr Anita Green. Sudden Cardiac Death

Cardiomyopathy. Jeff Grubbe MD FACP, Chief Medical Director, Allstate Life & Retirement

Cardiac hypertrophy and how it may break an athlete s heart e the Cypriot case

27-year-old professionnal rugby player: asymptomatic

Left atrial function. Aliakbar Arvandi MD

Heart Failure in Women: Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre

Dr Navin Chandra Clinical Research Fellow in Cardiology St George s University of London

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output

Evaluation of Left Ventricular Function and Hypertrophy Gerard P. Aurigemma MD

Dr. Dermot Phelan MB BCh BAO PhD European Society of Cardiology 2012

Aerobic Training Induced Structural Changes of the Heart

Endurance sports and sudden cardiac death

The athlete s heart: Different training responses in African and Caucasian male elite football players

EVALUATION OF ELECTROCARDIOGRAPHIC FINDINGS IN ATHLETES

Interpretation and Consequences of Repolarisation Changes in Athletes

Cardiac MRI: Cardiomyopathy

10/7/2013. Systolic Function How to Measure, How Accurate is Echo, Role of Contrast. Thanks to our Course Director: Neil J.

Slide 1. Slide 2. Slide 3. Sudden Cardiac Death In Athletes. Epidemiology. Epidemiology. Shaun McMurtry, MD Primary Care Sports Medicine

Michigan Society of Echocardiography 30 th Year Jubilee

Pre-participation screening is warranted: Pro

Role of CMR in heart failure and cardiomyopathy

Tissue Doppler and Strain Imaging

Pre-participation Screening for the Prevention of sudden Cardiac Death in Young Athletes. Thomas W. Allen, DO, MPH

Bernhard L. Gerber. Differentiating HCM from athletes heart. Role of contrast enhanced MR.

Prevalence of Modified ARVC Task Force Criteria in Elite Male Athletes

OPTIMIZING ECHO ACQUISTION FOR STRAIN AND DIASTOLOGY

Strain Imaging: Myocardial Mechanics Simplified and Applied

ECGs of structural heart disease: Part I

HEART CONDITIONS IN SPORT

ECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction

Asymptomatic Valvular Disease:

Tissue Doppler and Strain Imaging

What s New in Cardiac MRI

Evalua&on)of)Le-)Ventricular)Diastolic) Dysfunc&on)by)Echocardiography:) Role)of)Ejec&on)Frac&on)

Utility of Echocardiography

Rest and Exercise Echocardiography in Hypertrophic Cardiomyopathy: Determinants of Exercise Peak Gradient and Predictors of Outcome

RIGHT VENTRICULAR SIZE AND FUNCTION

Cardiovascular Impacts of long-term endurance exercise: Implications of athlete s heart

The Pathophysiology of Cardiogenic Shock Knowledge Gaps & Opportunities

DELAYED ENHANCEMENT IMAGING IN CHILDREN

SUDDEN CARDIAC DEATH IN ATHLETES

Martin G. Keane, MD, FASE Temple University School of Medicine

Abnormal ECG patterns and significance in a group of mountaineers

Long-term athletic training is associated with cardiac

Managing the Low Output Low Gradient Aortic Stenosis Patient

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention

Tissue Doppler and Strain Imaging. Steven J. Lester MD, FRCP(C), FACC, FASE

Dobutamine Stress testing In Low Flow, Low EF, Low Gradient Aortic Stenosis Case Studies

Hypertrophic Cardiomyopathy

Hypertension in Aortic Valve Disease

Alicia Armour, MA, BS, RDCS

Evaluation of Left Ventricular Diastolic Dysfunction by Doppler and 2D Speckle-tracking Imaging in Patients with Primary Pulmonary Hypertension

New ASE Guidelines: What you must know

Cardiac MRI: Clinical Application to Disease

Sports Cardiology Highlights from EuroPRevent 2012 Dublin

LV FUNCTION ASSESSMENT: WHAT IS BEYOND EJECTION FRACTION

Sudden cardiac death: Primary and secondary prevention

Normal ECG And ECHO Findings in Athletes

Transcription:

The Athlete s Heart Role of Echo Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University Washington, D.C.

Disclosures Grant support (to institution) for Core Lab activities: Abbott Vascular Boston Scientific Biotronic Direct Flow Edwards LifeScience Medtronic MitrAlign St. Jude Sorin/ Carbomedics For a full list, visit www.echocorelab.org

Special Thanks to: Malissa J. Wood, MD FACC FASE Co-director MGH Heart Center Corrigan Women s Heart Health Program Massachusetts General Hospital

Outline Principles of Exercise-induced Cardiac Remodeling Endurance vs. Strength training Healthy vs. Diseased (Athlete s heart vs. pathology) 1. LV chamber enlargement 2. RV chamber enlargement 3. LV wall thickening (gray zone hypertrophy) Is there a role for Echo in Screening Athletes? Identification and Prevention of Sudden Cardiac Death

Background: Sport-Specific Physiology Endurance Activities Strength Activities Sustained CO 4 to 5 times rest HR & SV Vasodilation Repetitive SBP Systolic BP > 200 mmhg Skeletal Muscle Contraction LV Afterload

Exercise-Induced Cardiac Remodeling Weiner & Baggish. Prog Cardiovasc Dis 2012;54:380.

Uncertainty #1: LV Dilatation 1309 Athletes in Diverse Sports (soccor, gymnastic, rowing) ~40% of male athletes Pelliccia et al. Ann Intern Med 1999;130:23.

LV Chamber Enlargement 25% of US college athletes exceed gender recommended LVIDd limit Weiner et al. J Am Soc Echocardiogr 2012;25:568.

Olympic Athletes: LV Volumes 100 LVEDV Stroke Volume ml / m 2 80 60 40 60 20 0 rower lifter ml / m 2 40 40 LVESV 20 30 ml / m 2 20 10 0 rower lifter 0 rower lifter Med Sci Sports Exerc. 2010 Jun;42(6):1215-20

LV Adaptation in Endurance Athletes Physiologic: Expected with endurance training. Accompanied by proportionate increase in LV mass (Eccentric LVH). Accompanied by normal to low normal resting LVEF (~50%). TDI / Strain assessment with preserved or enhanced function. Usually accompanied by other chamber enlargement (RV, LA). LVIDd absolute cut-offs are not helpful. When in doubt, exercise testing is very useful (confirm LV augmentation and document supranormal exercise capacity).

Uncertainty #2: RV Chamber Enlargement/Function 102 Endurance Athletes from the UK Oxborough et al. J Am Soc Echocardiogr 2012;25:263.

Pre-Marathon Post marathon Neilan, Circulation 2006

RV Function-Olympic Speedskaters Baseline Post-exertion P Value Ea (cm/sec) 13.5±3.6 15.2±5.8 0.041 Aa (cm/sec) 8.6±1.5 9.2±3.0 0.47 RV Area change 0.35 ± 0.13 0.43 ± 0.13 0.007 Strain Apex (%) -30±8-29±7 0.66 SR Apex (s -1 ) -1.8±0.5-2.5±1.2 0.038 Poh KK, Int J Cardiol 2008

RV Adaptations to training Physiologic: RV enlargement expected with endurance training. Global RV process without sacculation, aneurysmal dilation, segmental dysfunction, or fibrosis. RV dimensions absolute cut-offs are not usually helpful. Almost always associated with LV remodeling (concomitant LV enlargement but no RVH). May be accompanied by normal to low normal resting FAC / RVEF. TDI / Strain assessment should be preserved or enhanced function. If in doubt, comprehensive exercise testing RV demonstrates contractile reserve

Uncertainty #3: Thick LV Walls Least frequent but most problematic issue. Expected with strength (isometric) training. Gray Zone LVH: 13 15 mm Challenge: distinguish EICR from HCM Especially since HCM is leading cause of exercise-related sudden death

Thick LV Walls Not a single healthy college athlete with walls > 14 mm Weiner et al. J Am Soc Echocardiogr 2012;25:568.

LV Wall Thickness in 600 Female Athletes # Athletes 300 275 250 225 200 175 150 125 100 75 50 25 0 11 102 278 154 46 Pelliccia JAMA 1996:276:211 8 1 6 7 8 9 10 11 12 LV Wall Thickness (mm)

Thick LV Walls Adult Athletes (mostly rowing, track, soccor) 2% ( 13 mm) Pelliccia et al. N Engl J Med 1991.

Racial Differences in LV Remodeling in Highly Trained Athletes 300 Nationally Ranked Black Athletes compared to 300 Matched White Athletes and 150 B & W Sedentary people Blacks Athletes had Greater LV Thickness and Cavity Size 16% BA and 4% WA had wall thickness > 12 mm 3% BA and 0% WA had wall thickness >15mm BA with LVH had enlarged LVs and normal diastolic function Basavarajaiah JACC 2008;51:2256-62

Racial Differences in LV Remodeling in Highly Trained Athletes Basavarajaiah JACC 2008;51:2256-62

Olympic Athletes: LV Mass 200 LV Mass 150 g/m 2 100 50 0 rower lifter Baggish / Wood, 2008

Pathologic LVH (HCM) vs Physiologic LVH (Athletic Heart) Maron et al, Circz 2006;114:1633

LV Cavity Size 28 athletes without CV disease and 25 untrained patients with HCM (matched for LV wall thickness 13 15 mm) LVIDd <54 mm differentiated HCM and Athlete s heart Caselli et al. Am J Cardiol 2014;114:1382-89.

Other Distinguishing Features Tissue Doppler (Diastolic Function) E (septum) <11.5 cm/s (sens 81%, spec 61% for dx HCM) Caselli et al. Am J Cardiol 2014;114:1382-89.

Thick LV Walls Physiologic: Physiologic concentric LVH is symmetric without regional variation. Marked asymmetry is pathology until proven otherwise. Wall thickness cut-offs are VERY helpful. Accurate absolute thicknesses >15 mm are pathologic until proven otherwise. E values may be helpful, but not diagnostic Exercise testing may be useful discriminator (rule out other causes of LVH, i.e. hypertensive BP response) Detraining may be necessary to arrive at a final diagnosis.

Outline Principles of Exercise-induced Cardiac Remodeling Endurance vs. Strength training Healthy vs. Diseased (Athlete s heart vs. pathology) 1. LV chamber enlargement 2. RV chamber enlargement 3. LV wall thickening (gray zone hypertrophy) Is there a role for Echo in Screening Athletes? Identification and Prevention of Sudden Cardiac Death

Causes of Sudden Cardiac Death in Athletes Most Common: Hypertrophic CMP Anomalous origin coronary artery Less Common: Aortic Dilatation in Marfan Myocarditis Uncommon: Arrhythmogenic RV Cardiomyopathy Atherosclerotic CAD Aortic Valve Stenosis

Utility of Screening Echo Incidence of SCD during sports varies from <1/100,000 athletes* to 2/100,000 # In 2688 competitive athletes, 203 (7.5%) of echos were abnormal Only in 4 athletes did it stop athletic activity (HCM mostly) NO consensus on what type of echo to perform (handheld, limited, full, etc) Cost effectiveness is determined by 1) incidence of SCD related to sports practice 2) Cost of the echo 3) Years of potential life saved All of the above are either unknown or highly variable *Corrado et al, JAMA 2006;296:1593 # Steubvuk et al, JACC 2011;57:1291

Conclusions 1) Exercise training is a potent stimuli for cardiac remodeling and contributes to the development of athlete s heart morphology. 2) Understand the principles of exercise-induced cardiac remodeling 3) The nature and magnitude of cardiac remodeling depends upon sporting discipline, gender, race, level of and duration of training (Endurance vs. Strength). 4) Echocardiographic techniques can help differentiate healthy adaptation from underlying pathology 5) Echo can identify causes of SCD that are not caught with a screening ECG but the yield is still low and the cost-effectiveness is unknown